... Investment Management Inc. purchased a new position in CymaBay Therapeutics during the 4th quarter worth $115,000. Ardsley Advisory Partners increased its holdings in CymaBay Therapeutics by 66.2% during the 2nd quarter. Ardsley Advisory Partners ...
https://sportsperspectives.com/2018/02/04/valuengine-upgrades-cymabay-therapeutics-cbay-to-hold.html
No comments:
Post a Comment